The purpose of this study is to demonstrate feasibility, usability, and acceptability of VR-based cognitive and physical rehabilitation, evaluate adherence, tolerability, and fidelity to the VR intervention and explore preliminary effectiveness of VR-based rehabilitation on cognitive, physical, and functional outcomes
Clinical diagnosis of MCI (MoCA 18-26) or self-reported subjective cognitive decline (SCD)
Capacity to provide informed consent
Able to provide own transportation to sessions
Speaks and understands English
Uncontrolled seizures or epilepsy
Severe psychiatric illness or active suicidality
Inability to follow instructions or tolerate VR (severe motion sickness)
Cognitive impairment as a result of a known cause (e.g., dementia, stroke, Traumatic Brain Injury (TBI), medications, etc.)
The University of Texas Health Science Center, Houston
Lead sponsor
DPRIT Seed Grant
Collaborator